These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oxymetholone therapy in aplastic and other refractory anaemias. Sacks P, Gale D, Bothwell TH, Stevens K. S Afr Med J; 1972 Oct 28; 46(43):1607-15. PubMed ID: 4509113 [No Abstract] [Full Text] [Related]
7. [Development of polycythemia vera during chronic idiopathic myelofibrosis]. Paladini G, Tosato F, Mazzanti G, Covaz E. Minerva Med; 1985 Dec 22; 76(49-50):2315-7. PubMed ID: 4088526 [Abstract] [Full Text] [Related]
8. Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies. Barosi G, Elliott M, Canepa L, Ballerini F, Piccaluga PP, Visani G, Marchetti M, Pozzato G, Zorat F, Tefferi A. Leuk Lymphoma; 2002 Dec 22; 43(12):2301-7. PubMed ID: 12613516 [Abstract] [Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1999 Aug 22; 485():1-233. PubMed ID: 12571678 [Abstract] [Full Text] [Related]
16. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report. Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA. J Med Case Rep; 2018 Apr 24; 12(1):105. PubMed ID: 29685167 [Abstract] [Full Text] [Related]
19. [A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)]. Harashima S, Okamura T, Umeno M, Takaki K. Rinsho Ketsueki; 1996 Aug 24; 37(8):713-8. PubMed ID: 8827883 [Abstract] [Full Text] [Related]